APA (7th ed.) Citation

Sheffield, B. S., Eaton, K., Emond, B., Lafeuille, M., Hilts, A., Lefebvre, P., . . . Cheema, P. (2023, February). Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing versus Single-Gene Testing among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices. Current Oncology.

Chicago Style (17th ed.) Citation

Sheffield, Brandon S., et al. "Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing Versus Single-Gene Testing Among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices." Current Oncology Feb. 2023.

MLA (9th ed.) Citation

Sheffield, Brandon S., et al. "Cost Savings of Expedited Care with Upfront Next-Generation Sequencing Testing Versus Single-Gene Testing Among Patients with Metastatic Non-Small Cell Lung Cancer Based on Current Canadian Practices." Current Oncology, Feb. 2023.